Results for c‑reactive protein increased translation from English to Maltese

c-reactive protein increased
Żieda fi proteina reattiva Ċ

c-reactive protein
proteina reattiva Ċ

increased c-reactive protein
Żieda fil-proteina c- reattiva

c-reactive protein increased blood calcium decreased
Żieda fil-proteina reattiva c tnaqqis tal-kalċju fid-demm

c-reactive protein, mg/l
proteina reattiva għal c, mg/l

c-reactive protein increased, blood parathyroid hormone increased
żieda fil-proteina Ċ-reattiva, żieda fl-ormon tal-paratirojde fid-demm,

rare semen analysis abnormal, c-reactive protein increased, blood calcium decreased
analiżi tas-semen mhux normali, żieda fil-proteina reattiva Ċ, tnaqqis tal-kalċju fid-demm

increased protein (c-reactive protein) in blood indicating inflammation
Żieda fil-proteini (proteina ċ-reattiva) fid-demm li tindika infjammazzjoni

the reports of pyrexia and increased c-reactive protein concerned the same subject.
ir-rapporti ta’ deni u ż-żieda fil-proteina Ċ reattiva kienu jikkonċernaw lill-istess suġġett.

hyperbilirubinaemia*, protein analyses abnormal*, weight increased, blood test abnormal*, c-reactive protein increased
iperbilirubinemija*, valuri anormali tal-analiżi ta’ proteini*, Żieda fil-piż, valuri anormali tat-testijiet tad- demm*, Żieda fil-proteina li tirreaġixxi ma’ c

increased level of c-reactive protein, which can be seen in results of blood tests
livell ogħla ta’ proteina reattiva Ċ, li jista’ jidher fir-riżultati tat-testijiet tad-demm

it is well established that il-6 stimulates the acute-phase expression of c-reactive protein (crp).
huwa fatt stabbilit li il-6 jistimula l-espressjoni fil-fażi akuta tal-proteina reattiva c (crp - c-reactive protein).

high blood sugar (hyperglycaemia), increased salt, urea, creatinine and potassium in your blood blood test result indicating inflammation (c-reactive protein increased)
livell għoli ta’ zokkor fid-demm (ipergliċemija), żieda fil-melħ, urea, krejatinina u potassium fid- demm tiegħek riżultat tat-test tad-demm li jindika infjammazzjoni (żieda fil-proteina c-reattiva)

secukinumab has been shown to lower (within 1 to 2 weeks of treatment) levels of c-reactive protein, which is a marker of inflammation.
intwera li secukinumab għandu livelli aktar baxxi (fi żmien ġimgħa sa ġimgħatejn ta’ kura) ta’ proteina reattiva c, li huwa indikatur ta’ infjammazzjoni.

the effects of tocilizumab on c-reactive protein (crp), neutrophils and signs and symptoms of infection should be considered when evaluating a patient for a potential infection.
meta pazjent jiġi vvalutat għall-infezzjoni potenzjali, għandhom jiġu kkunsidrati l-effetti ta’ tocilizumab fuq il-proteina Ċ-reattiva (crp), newtrofili u sinjali u sintomi ta’ infezzjoni.

blood pressure increased, electrocardiogram st segment depression, electrocardiogram t wave amplitude decreased, heart rate increased, liver function test abnormal, platelet count decreased, weight increased, semen abnormal, c-reactive protein increased, blood calcium decreased
pressjoni tad- demm aktar għolja, depressjoni fis- segment st fuq l - elektrokardjogramm, tnaqqis fil- wisa 'tat- t wave fuq l - elektrokardjogramm, żieda fir- ritmu tal- qalb, test tal- funzjoni tal- fwied mhux normali, tnaqqis fl- għadd tal- pjastrini, żieda fil- piż, semen abnormali, żieda fil- proteina c- reattiva, tnaqqis tal- kalċju fid- demm

prolonged prothrombin time, prolonged activated partial thromboplastin time, increased international normalised ratio, increased blood alkaline phosphatase, increased blood lactate dehydrogenase, increased c-reactive protein, cytomegalovirus antibody positive
Ħin imtawwal tal- prothrombin, ħin imtawwal tat- thromboplastin parzjali attivat, żieda fl - inr (international normalised ratio), żieda fl- alkaline phosphatase fid - demm, żieda fil- lactate dehydrogenase fid- demm, żieda fis- c- reactive protein, cytomegalovirus antikorp pożittiv

at 600 mg, one subject experienced oedema of the feet and hands, and increases in creatine phosphokinase (cpk), ast, c-reactive protein (crp) and myoglobin levels.
b’600 mg, individwu wieħed kellu edema ta’ l-idejn u tas-saqajn, u żiediet fil-creatine phosphokinase (cpk), ast, proteina reattiva-c (crp) u fil-livelli tal- majoglobina.

after infliximab treatment, patients exhibited decreased levels of serum interleukin 6 (il-6) and c-reactive protein (crp), and increased haemoglobin levels in rheumatoid arthritis patients with reduced haemoglobin levels, compared with baseline.
wara kura b’infliximab, il-pazjenti wrew tnaqqis fil-livelli ta’ interleukin 6 (il-6) fis-serum u proteina reattiva-Ċ (crp), u żieda fil-livelli ta’ emoglobina f’pazjenti b’artrite rewmatojde b’livelli aktar baxxi ta’ emoglobina, meta mqabbel mal-linja bażi.

the distribution of the related adrs is as follows: one report of pyrexia and one report of increased c-reactive protein in one subject, one case of urticaria in one subject, one report of pruritus, one report of rash and one report of dizziness in one subject.
it- tqassim ta 'l- adrs relatati huwa kif ġej: rapport wieħed ta' deni u rapport wieħed ta 'proteina Ċ- reattiva akbar f' suġġett wieħed, każ wieħed ta' urtikarja f' suġġett wieħed, rapport wieħed ta 'ħakk rapport wieħed ta' raxx u rapport wieħed ta 'sturdament f' suġġett wieħed.